Why ENDRA Life Sciences Stock Is Trading Higher Monday

ENDRA Lifesciences filed a 13G form showing that S.H.N. Financial Investments had a 9.99% passive stake in the company.

ENRDA Life Sciences, Inc. (NASDAQ:NDRA) shares are moving higher Monday after a 13G form was filed by the company on Friday.

The Details: ENDRA Lifesciences filed a 13G form with the Securities Exchange Commission showing that S.H.N. Financial Investments had a 9.99% passive stake in the company.

Specifically, S.H.N Financial Investments owns approximately 7.9 million shares in the company.

How To Buy ENDRA Life Sciences Stock

Besides going to a brokerage platform to purchase a share – or fractional share – of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument.

For example, in ENDRA Life Sciences’ case, it is in the Health Care sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.

Related Link: Why Nurix Therapeutics Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket

NDRA Price Action: At the time of writing, ENDRA Life Sciences stock is trading 14.6% higher at 11 cents, according to data from Benzinga Pro.

Image: Image from Shutterstock

Total
0
Shares
Related Posts
Read More

KORE Group, SeaChange International And 2 Other Stocks Under $2 Insiders Are Aggressively Buying

The Dow Jones settled lower by more than 300 points on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

CRTD